Passer au contenu principal

Medical Subject Headings (thesaurus)

Choisissez le vocabulaire dans lequel chercher

aligner
annoter
télécharger

Concept information

... > Chemical Actions and Uses > Toxic Actions > Noxae > Antimetabolites > Hypolipidemic Agents > Anticholesteremic Agents > PCSK9 Inhibitors
... > Chemical Actions and Uses > Pharmacologic Actions > Molecular Mechanisms of Pharmacological Action > Antimetabolites > Hypolipidemic Agents > Anticholesteremic Agents > PCSK9 Inhibitors
... > Chemical Actions and Uses > Pharmacologic Actions > Therapeutic Uses > Lipid Regulating Agents > Hypolipidemic Agents > Anticholesteremic Agents > PCSK9 Inhibitors
... > Chemical Actions and Uses > Pharmacologic Actions > Molecular Mechanisms of Pharmacological Action > Enzyme Inhibitors > Protease Inhibitors > Serine Proteinase Inhibitors > PCSK9 Inhibitors

Terme préférentiel

PCSK9 Inhibitors  

Type

  • mesh:Descriptor

Définition

  • Agents that inhibit Proprotein Convertase Subtilisin/Kexin Type 9 (see PROPROTEIN CONVERTASE 9 (PCSK9)), an enzyme that plays an important role in the degradation of the LDL receptors. It favors LDL catabolism and reduces plasma LDL-cholesterol (LDL_C) level.

Concept générique

Qualificatif(s) autorisé(s)

Traductions

URI

http://data.loterre.fr/ark:/67375/JVR-F69ZKPPR-N

Télécharger ce concept :

RDF/XML TURTLE JSON-LD Date de création 09/07/2021, dernière modification le 08/07/2021